Torrent Pharmaceuticals Limited has informed the Exchange about General Updates
TORNTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Torrent Pharmaceuticals has informed the stock exchanges that the National Company Law Tribunal (NCLT), Ahmedabad Bench, has issued a Corrigendum Order dated 24th March 2026 in connection with the proposed Scheme of Amalgamation of J.B. Chemicals & Pharmaceuticals Limited (Transferor Company) with Torrent Pharmaceuticals Limited (Transferee Company). This intimation is a continuation of an earlier disclosure made on 24th March 2026 regarding the Tribunal's order on the merger. The corrigendum has been uploaded on the NCLT website (nclt.gov.in) on 25th March 2026. A corrigendum typically represents a minor correction or clarification to the original order rather than a substantive change. The filing is made under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.
This is a procedural update suggesting the NCLT's approval process for the Torrent Pharma–JB Chemicals merger is still moving forward, though shareholders should wait for clarity on what the corrigendum specifically corrects. The merger is a significant consolidation event in the Indian pharma space and progress updates could influence short-term sentiment on the stock.